Over 321 million shares outstanding already per the 10-K that was just filed. What will the float look like after those who have all the shares at .07, .08, and .14 cents etc. bleed their shares into the float?
I know! The muppets will still be asleep dreaming of buried treasure in faraway lands and fantasizing that they too will get a ride on Bennett LeBow's yacht or be invited to Frost's castle on Star Island.
Sentiment: Strong Sell
Got to start somewhere. I need the negative guys to show up everyday while I accumulate. This week you guys did not do a good job bashing. I was hoping to buy some more on dips but the positve post on this board was so overwhelming for the shorts(which all the information I already new)....Very dissppointed in the shorts this week. I am axious to buy more. I bought a little bit more Monday, but I should of have bought more.
Here's a DD challenge for red-thumb "red900901". Ask him to do some DD on Tod Woolf ( former CEO ) and his "programmable soda bottles" venture a few years ago. How did that one turn out?
Oh, and ask red to report back to the message board on who Advirna LLC is, who's involved, and what the role is in RXI?
Thanks, Uncle Ed
ed. These pumpers aren't interested in DD. They have a preconceived storyline their trying to push.
IF they were in good faith they would have attemped to answer in good faith.
Sentiment: Strong Sell
First, what loser signs off "Uncle Ed"? Sounds a bit like a pedophile to me. Secondly, why would anyone care that Woolf failed at something else? Branson, Cuban, Jobs, Trump, and about every other successful person failed at something on their way up. If that is why you are telling people to short this stock then once again it is pitiful. You ask everyone to answer your DD questions. Here is one for you. Logically explain to everyone on this board why rxii will fail. List reasons why it is doomed. Facts based on 2013 research not 2004.
Tod Woolf, the RXI "founder" and Programmable Soda Bottle king also appears to be the business "advisor" for Advirna LLC
Advirna has been founded by Drs. Anastasia Khvorova and Alexey Wolfson in 2007 in Boulder CO to develop new nucleic based technologies for therapeutic and research use. Advirna has developed a proprietary self-deliverable RNAi technology and reduced it to practice in collaboration with RXi Pharmaceuticals. In 2010 Advirna moved its operations to central Massachusetts. Advirna’s goal is to develop a novel self-deliverable RNAi technology platform to provide researchers with better tools to study and manipulate activity of genes in living cell.